C5AR1 and Alzheimer disease: Further support of a protective role of a C5aR1 antagonist is the rescue of the excessive synaptic loss and decreased AD-like pathology in 2 other mouse models of AD [22] that correlates with memory loss and cognitive decline parameters seen in human AD [42].